Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.80% Nasdaq Up 0.97%
Streaming
Ticker Tape: On

Synageva BioPharma Corp. (GEVA)

-NasdaqGS

39.87 Up 0.04(0.10%) May 17, 4:00PM EDT|After Hours : 39.87 0.00 (0.00%) May 17, 4:32PM EDT

Add to Portfolio
Prev Close:39.83
Open:40.33
Bid:10.17 x 2000
Ask:N/A
1y Target Est:59.43
Beta:0.73
Next Earnings Date:29-Jul-13GEVA Earnings announcement
Day's Range:39.79 - 40.37
52wk Range:34.01 - 58.00
Volume:108,993
Avg Vol (3m):100,627
Market Cap:1.09B
P/E (ttm):N/A
EPS (ttm):-2.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GEVA

Comparison

Symbol% ChgMkt Cap
GEVAUp 0.10%1.09B
RHHBYN.MXDown 0.45%2.65T
SHP.LDown 0.19%11.31B
SUNPHARMA.NSDown 0.28%1.00T
GILD.MXUp 0.11%1.04T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):61.45
Ex-Dividend Date:30-Dec-08

Analysts

Annual EPS Est (Dec-13) :-3.25
Quarterly EPS Est (Jun-13) :-0.78
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synageva BioPharma Corp., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback